ZA776260B - N-substituted lactams - Google Patents

N-substituted lactams

Info

Publication number
ZA776260B
ZA776260B ZA00776260A ZA776260A ZA776260B ZA 776260 B ZA776260 B ZA 776260B ZA 00776260 A ZA00776260 A ZA 00776260A ZA 776260 A ZA776260 A ZA 776260A ZA 776260 B ZA776260 B ZA 776260B
Authority
ZA
South Africa
Prior art keywords
substituted lactams
lactams
substituted
Prior art date
Application number
ZA00776260A
Other languages
English (en)
Inventor
L Marchal
L Rodriquez
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of ZA776260B publication Critical patent/ZA776260B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
ZA00776260A 1976-10-22 1977-10-20 N-substituted lactams ZA776260B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43934/76A GB1539817A (en) 1976-10-22 1976-10-22 N-substituted lactams

Publications (1)

Publication Number Publication Date
ZA776260B true ZA776260B (en) 1978-07-26

Family

ID=10431009

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00776260A ZA776260B (en) 1976-10-22 1977-10-20 N-substituted lactams

Country Status (27)

Country Link
US (1) US4162325A (sv)
JP (1) JPS5839148B2 (sv)
AT (1) AT352742B (sv)
BE (1) BE859925A (sv)
BG (1) BG28413A3 (sv)
CA (1) CA1095040A (sv)
CH (1) CH625214A5 (sv)
CS (1) CS200231B2 (sv)
CY (1) CY1037A (sv)
DD (1) DD131930A5 (sv)
DE (1) DE2747369A1 (sv)
DK (1) DK461877A (sv)
ES (1) ES463424A1 (sv)
FI (1) FI66600C (sv)
FR (1) FR2368474B1 (sv)
GB (1) GB1539817A (sv)
HK (1) HK2380A (sv)
HU (1) HU174864B (sv)
IL (1) IL53171A (sv)
KE (1) KE3013A (sv)
MY (1) MY8000264A (sv)
NL (1) NL7711414A (sv)
PL (1) PL110679B1 (sv)
SE (1) SE425782B (sv)
SU (2) SU805945A3 (sv)
YU (1) YU251977A (sv)
ZA (1) ZA776260B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE27T1 (de) * 1978-05-08 1981-04-15 Ucb Sa Lactam-n-essigsaeuren und ihre amide, verfahren zu ihrer herstellung und heilmittel, die sie enthalten
FI840261A (fi) * 1983-01-27 1984-07-28 Ciba Geigy Ag Substituerade pyrrolidinonderivat och foerfarande foer deras framstaellning.
EP0115472A3 (de) * 1983-01-27 1985-10-02 Ciba-Geigy Ag Pyrrolidinonderivate und Verfahren zu ihrer Herstellung
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0419683A4 (en) * 1989-04-13 1992-03-11 Japan Tobacco Inc. New amino acid derivatives having prolylendopeptidase inhibitor activity
US5206386A (en) * 1991-03-20 1993-04-27 Isp Investments Inc. Controlled release N-substituted pyrrolidone esters and process for the use thereof
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
CN114685342B (zh) * 2020-12-25 2024-05-10 长沙博源医疗科技有限公司 一种左乙拉西坦衍生物、免疫原、抗左乙拉西坦特异性抗体及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121723A (en) * 1955-11-02 1964-02-18 Sterling Drug Inc Lower alkyl n-(tertiary-amino-lower-alkyl) lower alkamates and quaternary ammonium salts thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
NL7407140A (nl) * 1974-03-07 1975-09-09 Jose Maria Espinos Taya En Jos Werkwijze voor de bereiding van een n-gesub- stitueerd pyrrolidon.
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins

Also Published As

Publication number Publication date
AT352742B (de) 1979-10-10
JPS5353649A (en) 1978-05-16
JPS5839148B2 (ja) 1983-08-27
HK2380A (en) 1980-01-25
IL53171A (en) 1982-02-28
ATA749677A (de) 1979-03-15
BE859925A (fr) 1978-04-20
PL201601A1 (pl) 1979-01-29
CS200231B2 (en) 1980-08-29
US4162325A (en) 1979-07-24
FI773069A (fi) 1978-04-23
CA1095040A (en) 1981-02-03
MY8000264A (en) 1980-12-31
IL53171A0 (en) 1977-12-30
CY1037A (en) 1980-08-01
PL110679B1 (en) 1980-07-31
FI66600B (fi) 1984-07-31
SE425782B (sv) 1982-11-08
NL7711414A (nl) 1978-04-25
BG28413A3 (en) 1980-04-15
FR2368474B1 (fr) 1980-08-08
DE2747369C2 (sv) 1987-11-12
HU174864B (hu) 1980-03-28
DE2747369A1 (de) 1978-04-27
YU251977A (en) 1983-01-21
SU937450A1 (ru) 1982-06-23
DD131930A5 (de) 1978-08-09
GB1539817A (en) 1979-02-07
KE3013A (en) 1980-02-01
SE7711667L (sv) 1978-04-23
FI66600C (fi) 1984-11-12
FR2368474A1 (sv) 1978-05-19
SU805945A3 (ru) 1981-02-15
DK461877A (da) 1978-04-23
ES463424A1 (es) 1978-07-16
CH625214A5 (sv) 1981-09-15

Similar Documents

Publication Publication Date Title
ZA776241B (en) Amide compounds
ZA785698B (en) Amides
NZ183536A (en) N-(w-aminoalkyl) heterocycles
JPS53104694A (en) Hydrolysissstabilized copolyetherrester amide
JPS52140093A (en) Fitting block
KE3013A (en) N-substituted lactams
JPS57140764A (en) N-substituted biscarbamoylsulfide compound
NZ186329A (en) N-substituted phenylergolin-8-ylcarboxamides
AU510454B2 (en) N-substituted pyrrolidines
AU2047376A (en) Pyrrolidones
AU1517776A (en) Pyrrolidones
AU2530577A (en) Cyclic amides
ZA785351B (en) N-substituted benzothiazolines
AU4073278A (en) N-substituted mercaptomethylacetamidines
ZA774521B (en) Isoindol derivatives
ZA773852B (en) Amides
PT66727B (en) Amides
ZA771881B (en) Polyamides
ZA772564B (en) N-substituted propenyl-naphthyl methylamines
JPS52109179A (en) Timing means
AU1530676A (en) Pyrrolidones
IT7948984A0 (it) Lattami n-sostituiti
KR780000577Y1 (en) Embankmant block
CA40559S (en) Block
ZA77387B (en) N-(alpha-aminoalkylidne)phosphor-and phosphomamidates